Viewing Study NCT05164601



Ignite Creation Date: 2024-05-06 @ 5:01 PM
Last Modification Date: 2024-10-26 @ 2:20 PM
Study NCT ID: NCT05164601
Status: COMPLETED
Last Update Posted: 2024-06-18
First Post: 2018-11-07

Brief Title: Prognosis of Acute Coronary Syndrome
Sponsor: Xiang Xie
Organization: Xinjiang Medical University

Study Overview

Official Title: A Multicenter Prospective Cohort Study Evaluating the Prognosis of Patients With Acute Coronary Syndrome
Status: COMPLETED
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: MPCS-ACS
Brief Summary: The MPCS-ACS Study Multicenter Prospective Cohort Study on Acute Coronary Syndrome is a comprehensive forward-looking research project designed to understand the prognostic outcomes of patients diagnosed with acute coronary syndrome Leveraging a multicenter approach the study aims to collect data from a diverse group of patients thereby enhancing the generalizability and relevance of its findings Upon patient enrollment a range of information will be carefully gathered including demographic details clinical history and key biochemical markers The study also intends to document the various medication regimens prescribed during hospital stays to evaluate their impact on patient outcomes A pivotal aspect of MPCS-ACS is its thorough follow-up protocol where patients are regularly monitored to track their recovery progress and the occurrence of any subsequent cardiovascular events after discharge This methodical follow-up is designed to yield critical insights into the long-term prognosis of patients with acute coronary syndrome ultimately aiding in the refinement of treatment approaches and elevating the standard of patient care across all participating centers
Detailed Description: The Multicenter Acute Coronary Syndrome Prognosis Cohort Study MPCS-ACS is an extensive longitudinal research initiative designed to explore the prognostic outcomes of patients diagnosed with acute coronary syndrome ACS across various healthcare settings This collaborative effort will involve numerous hospitals and aims to capture and analyze data from ACS patients admitted from June 1 2016 to May 31 2021

Data collection will encompass a wide array of variables highlighting therapeutic interventions biochemical markers pertinent to ACS and its management alongside essential demographic and clinical history information This initiative seeks to thoroughly understand the treatment dynamics for ACS during this timeframe and evaluate their efficacy

Follow-up procedures are integral to the MPCS-ACS featuring routine evaluations every six months to a year after patients are discharged These check-ins will employ both direct interactions and telecommunication to maintain a strong connection with participants catering to those unable to visit the hospitals This approach is designed to enhance participation rates and data quality underpinning the studys credibility and the significance of its conclusions

With its comprehensive methodology and operational rigor the MPCS-ACS aspires to shed light on the prognostic determinants and outcomes of ACS patients ultimately aiming to refine patient care strategies and elevate treatment benchmarks within the domain of cardiovascular healthcare

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None